El Hindy M, Hezwani M, Corry D, Hull J, El Amraoui F, Harris M, et al
Liraglutide (Victoza) was approved in 2010, followed by Saxenda (for weight loss) in 2014.33 Semaglutide (Ozempic) was approved in 2017, Wegovy (for weight loss) in 2021, and Rybelsus (oral) shortly thereafter
Collaboration The importance of collaboration in meeting the needs of victims of human trafficking cannot be overstated
In November 2025, President Trump negotiated a deal with Eli Lilly and Novo Nordisk to reduce the price of GLP-1 drugs, resulting in a new voluntary program that allows Medicare beneficiaries to pay $50 for a months supply of GLP-1 drugs
What if these agents are psychiatric drugs that are masquerading as weight-loss drugs? Alzheimers disease Alzheimers is a progressive neurodegenerative disorder characterized primarily by problems with memory and cognition